phosphate binder

The US FDA Has Approved Vifor Pharma's Hyperphosphatemia Drug Velphoro
Dec 3, 2013
The US Food and Drug Administration (FDA) has approved Vifor Pharma's hyperphosphatemia drug Velphoro for the control of serum phosphorus levels in patients with Chronic Kidney Disease (CKD) on dialysis. Approval of Velphor, which is an ...

Tags: Drug, phosphate binder
OPKO Health Has Signed a Definitive Agreement to Acquire Cytochroma
Jan 14, 2013
Multinational pharmaceutical and diagnostics company OPKO Health has signed a definitive agreement to acquire Cytochroma. Under the purchase, OPKO intends to include Cytochroma's Replidea and Alpharen, which are in Phase 3 clinical trials ...

Tags: OPKO Health, Cytochroma, CKD, pharmaceutical
Japan Tobacco Has Filed a New Drug Application for The Marketing Approval
Jan 9, 2013
Japan Tobacco (JT), Keryx Biopharmaceuticals' Japanese partner, has filed a new drug application (NDA) for the marketing approval of Ferric Citrate (Zerenex) in Japan for the treatment of hyperphosphatemia in chronic kidney disease (CKD) ...

Tags: Ferric Citrate, Tobacco, CKD, Pharmaceutical